See a health care professional right away if you are unable to urinate or have severe pain in your abdomen. Acute urinary retention can be life threatening.11

Key facts

  • One national urology guideline describes size ranges from about 30 to 80 cc for TURP up to prostates over 80 cc for simple prostatectomy (open or robotic).
  • Enucleation techniques such as HoLEP are described for prostates over about 30 cc when a trained surgeon performs them, with a learning curve estimated at more than 20 to 50 cases.
  • In one randomized trial of prostates larger than 100 grams, HoLEP and open prostatectomy had similar 5-year results, with low reoperation in both groups.
  • Aquablation has published 5-year single-arm data in prostates from about 80 to 150 mL, with results similar to its original 30-to-80 mL trial.
  • Interventional-radiology practice guidance published in 2026 says PAE can be appropriate for prostates of 50 mL or more and describes no upper size limit, including very large glands over 150 mL. This is an ungraded consensus statement7. The large-prostate PAE studies cited here are retrospective or small, uncontrolled series8,9.
  • UroLift and Rezum have mainly been described for prostates under about 80 cc: Rezum including prostates with a middle lobe, and UroLift in prostates with a small-to-moderate middle lobe1.

Guideline size ranges

One national urology guideline groups procedures by prostate size, not by what a reader should choose. Transurethral resection (TURP) is described for prostates of about 30 to 80 cc, and is described elsewhere as "the most common and most proven surgical treatment for BPH."1,2 Enucleation techniques, such as HoLEP, are described for prostates over about 30 cc when performed by a trained surgeon, with a learning curve estimated at more than 20 to 50 cases1. Simple prostatectomy — done open or with robotic assistance — is described as "a procedure to remove the inside part of the prostate gland"2 for prostates larger than about 80 cc1. Photoselective vaporization (PVP) is described with "no size or shape limitation"1. These are study and guideline ranges, not a personal eligibility test.

Questions for your urologist

  • Which procedures have been studied at my prostate's size?
  • Does my prostate have a middle lobe or other feature that changes which options apply?
  • How many cases at my size have you done, and what was your learning curve?

Questions for your interventional radiologist

  • Is PAE an option to discuss at my prostate's size, based on the published evidence?
  • How many large or very large prostates have you treated with PAE?
  • Should I also see a urologist before we schedule anything?

Enucleation and simple prostatectomy

In a randomized trial of men with prostates larger than 100 grams, HoLEP and open simple prostatectomy produced similar symptom improvement at 5 years. Reoperation was similarly low in both groups — 5% after HoLEP and 6.7% after open surgery, in a trial that randomized 120 men, 74 of whom completed 5-year follow-up3. Robotic simple prostatectomy is also used for large prostates; no study comparing it directly with HoLEP is cited here.

Questions to ask

  • Is HoLEP available at my size, and how does it compare with open or robotic surgery for me?
  • What hospital stay, catheter time, and recovery should I expect with each approach?
  • How is bleeding managed during enucleation or open surgery?

Aquablation in larger glands

Aquablation was first tested against TURP in a randomized trial of prostates about 30 to 80 mL4,6. A later single-arm study followed 101 men with prostates averaging 107 mL, in the 80-to-150 mL group, for 5 years: symptom scores fell from 22.6 to 6.8, and 96.3% of men had not needed a second BPH procedure by year 55. A comparison of the original and larger-gland groups found similar symptom improvement and similar freedom from retreatment — 95% and 97% — in each group6. The later single-arm study did not compare Aquablation against another treatment.

Questions to ask

  • Has Aquablation been studied at my prostate's size, and was that study randomized or single-arm?
  • What catheter time and recovery should I expect?
  • How does bleeding risk change with a larger gland?

PAE and prostate size

Interventional-radiology practice guidance published in 2026 says PAE can be appropriate for prostates of 50 mL or more. Prostates of 30 to 49 mL may be considered case by case, though the evidence is strongest at 50 mL and above. The guidance states there is no upper size limit, including large prostates over 80 mL and very large prostates over 150 mL, and it describes repeated or hard-to-control bleeding from the prostate as a separate reason to consider PAE, regardless of size7. This is an ungraded consensus statement, not a graded recommendation, and it describes what the guidance says rather than whether PAE is right for a particular reader.

Published series of men with large prostates report symptom improvement after PAE. In one retrospective series of 93 men with an average prostate size of 141.7 mL, symptom scores fell from 22.3 to 7.3 at 12 months; one man had a stroke reported as a complication8. A small, short-term series of 8 men with prostates over 200 mL found that 3 of the 4 men who needed a catheter beforehand no longer needed one afterward9. Both are retrospective or small, uncontrolled series, not randomized trials. In a randomized trial that was not limited to large prostates, the 5-year improvement after PAE was smaller than after TURP10.

Questions to ask

  • Does the published PAE evidence at my prostate's size come from a randomized trial or a smaller series?
  • What would symptom improvement or catheter independence realistically look like for someone my size, based on the studies you'd point to?
  • Could repeated or hard-to-control bleeding from my prostate be a separate reason to discuss PAE?

UroLift, Rezum, and size

UroLift and Rezum have mainly been described for prostates under about 80 cc, including Rezum in prostates with a middle lobe. iTind has been studied in prostates of about 30 to 80 cc1. These ranges, and whether a middle lobe is present, are a reason to ask about rather than assume.

Questions to ask

  • Is my prostate's size and shape inside the range these devices were studied in?
  • If my prostate is outside that range, what are the alternatives?

Durability and retreatment

The same national urology guideline says patients should be informed of "lack of long-term durability" with PAE1. Ask how often people need another procedure with each option, and over what follow-up period, since published follow-up differs by study.

Questions to ask

  • How often do people need a second procedure after each option, and at what point after treatment?
  • How does the chance of needing another procedure change with a larger prostate?

Read how size itself is measured in prostate size and anatomy terms, and see how PAE compares with TURP or with Rezum and UroLift. For how each option can affect sex, read sexual side effects by treatment. Bring questions to ask before PAE, and talk with your doctor. More enlarged-prostate topics are in the BPH article library and on the BPH treatment options page.

Common questions

What counts as a very large prostate?

There's no single size cutoff. Guidelines and studies use different ranges for different procedures, from about 30 to 80 cc for TURP1 to practice guidance that includes PAE in glands over 150 mL7. This page describes those ranges as study and guideline context, not a personal size cutoff.

Is HoLEP or simple prostatectomy an option for a very large prostate?

Enucleation techniques such as HoLEP are described for prostates over about 30 cc when a trained surgeon performs them1. Simple prostatectomy, done open or with robotic assistance, is described for prostates larger than about 80 cc1. In one randomized trial of prostates larger than 100 grams, HoLEP and open prostatectomy had similar 5-year results and a similarly low chance of needing another procedure3.

Does Aquablation work on larger prostates?

Aquablation was first tested against TURP in a randomized trial of prostates about 30 to 80 mL4,6. A later single-arm study followed men with prostates from about 80 to 150 mL for 5 years and found symptom improvement and freedom from a second procedure similar to the original size group5,6, though that later study did not compare Aquablation against another treatment.

Can prostate artery embolization (PAE) treat a very large prostate?

Interventional-radiology practice guidance published in 2026 says PAE can be appropriate for prostates of 50 mL or more, and that prostates of 30 to 49 mL may be considered case by case, though the evidence is strongest at 50 mL and above. It describes no upper size limit, including very large glands over 150 mL, as an ungraded consensus statement, not a graded recommendation7. Published series of men with large prostates report symptom improvement after PAE, but most of that evidence is retrospective or from small, uncontrolled groups, not randomized trials8,9. One national urology guideline says patients should be informed of lack of long-term durability with PAE1.

How do I find out which option fits my prostate?

This page doesn't tell you which option fits you. Bring your prostate size and shape, including whether you have a middle lobe, to a urologist and an interventional radiologist, and ask which procedures have been studied at that size and what the evidence looks like for each.

Ready to build your BPH checklist?

Select the topics that apply to your upcoming non-urgent visit and get a personalized question checklist to bring to your clinician.

Build my BPH checklist

Sources

  1. Canadian Urological Association (CUA) BPH guideline, 2022 (PMID 35905485) ↩︎
  2. MedlinePlus, "Enlarged prostate," reviewed 2025 ↩︎
  3. Kuntz et al., European Urology 2008 (PMID 17869409) ↩︎
  4. Gilling et al., randomized trial of Aquablation vs TURP, 2018 (PMID 29360529) ↩︎
  5. Bhojani et al., Journal of Urology 2023 (PMID 37115632) ↩︎
  6. Berjaoui et al., BJUI Compass 2024 (PMID 39539565) ↩︎
  7. Mouli et al., Society of Interventional Radiology (SIR) 2026 PAE practice guidance (PMID 42223385) ↩︎
  8. Bhatia et al., Journal of Vascular and Interventional Radiology 2018 (PMID 30217744) ↩︎
  9. Mathevosian et al., Journal of Vascular and Interventional Radiology 2019 (PMID 31587945) ↩︎
  10. Müllhaupt et al., European Urology Focus 2024 (PMID 38531756) ↩︎
  11. NIDDK, "Symptoms and Causes of Urinary Retention" ↩︎